title: Hematopoietic hormones: from cloning to clinic.
abstract: In order to maintain adequate circulating numbers of blood cells, the bone marrow must produce billions of cells each day and must be able to rapidly increase production by 10-20-fold in response to infection and hemorrhage. The existence of circulating factors that regulate this process has been suspected for over 100 years. Recently, the genes encoding these growth factors were cloned and their functions are now identified. Interleukin-3 (IL-3) acts on the most primitive hematopoietic stem cell, driving this self-renewing cell to produce progeny of all hematopoietic lineages. Granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates the granulocyte-macrophage progenitor cell, as well as cells committed to the erythroid lineage, to differentiate. G-CSF and M-CSF stimulate the most differentiated myeloid progenitors to produce granulocytes and monocytes/macrophages, respectively. Erythropoietin stimulates the differentiation of late erythroid progenitors. In the lymphoid progenitor lineage, IL-2 stimulates T cell differentiation; IL-4 and IL-6 stimulate differentiation of B cells. The colony-stimulating factors also enhance function and cause activation of the mature cells whose production they induce. In clinical trials, these hormones have successfully ameliorated anemia in renal failure, chronic disease, and in prematurity. They have improved pancytopenias in aplastic anemia, myelodysplastic syndromes, and congenital cytopenias, and they have hastened recovery from chemotherapy and bone marrow transplantation.
authors.affiliation: Division of Pediatric Hematology/Oncology, Research Institute, Children's Hospital Medical Center, Oakland, California 94609.
authors.forename: S P
authors.initials: SP
authors.lastname: Perrine
authors.forename: E
authors.initials: E
authors.lastname: Vichinsky
authors.forename: D V
authors.initials: DV
authors.lastname: Faller
mesh_terms: D003001:Cloning, Molecular; D003115:Colony-Stimulating Factors / Q000502:physiology* / Q000627:therapeutic use; D004921:Erythropoietin / Q000502:physiology* / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000628:therapy; D006410:Hematopoiesis; D006801:Humans
chemical_list: D003115:Colony-Stimulating Factors; D004921:Erythropoietin